What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
His primary areas of study are Drug resistance, Virology, Acquired immunodeficiency syndrome, Immunology and Internal medicine.
His biological study spans a wide range of topics, including Bioinformatics, Transmission, HIV drug resistance and Pharmacology, Drug.
His Virology research incorporates elements of Mutation, Genetics, Reverse transcriptase and Raltegravir.
The Acquired immunodeficiency syndrome study combines topics in areas such as Expanded access, Epidemiology and Intensive care medicine.
His research in Internal medicine intersects with topics in Gastroenterology, Lamivudine, Sexually transmitted disease and Nevirapine.
Deenan Pillay studied Viral load and Cohort study that intersect with Pharmacotherapy.
His most cited work include:
- Update of the Drug Resistance Mutations in HIV-1. (1203 citations)
- British HIV Association guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 (1031 citations)
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update (707 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Virology, Drug resistance, Immunology, Viral load and Acquired immunodeficiency syndrome.
He focuses mostly in the field of Virology, narrowing it down to matters related to Reverse transcriptase and, in some cases, Mutation.
His Drug resistance research incorporates elements of Transmission, HIV drug resistance, Resistance mutation, Genotype and Drug.
His studies examine the connections between Immunology and genetics, as well as such issues in Antiretroviral therapy, with regards to Intensive care medicine.
His Viral load research includes elements of Regimen, Internal medicine, Pharmacotherapy, Lamivudine and Nevirapine.
His Acquired immunodeficiency syndrome research is multidisciplinary, relying on both Demography and Environmental health.
He most often published in these fields:
- Virology (43.88%)
- Drug resistance (36.45%)
- Immunology (30.70%)
What were the highlights of his more recent work (between 2016-2021)?
- Demography (16.07%)
- Public health (10.31%)
- Viral load (28.78%)
In recent papers he was focusing on the following fields of study:
Deenan Pillay mainly investigates Demography, Public health, Viral load, Acquired immunodeficiency syndrome and Psychological intervention.
His studies in Demography integrate themes in fields like Young adult, Incidence and Cohort.
Deenan Pillay has included themes like Internal medicine, Interquartile range, Lamivudine and Nevirapine, Antiretroviral therapy in his Viral load study.
Deenan Pillay works mostly in the field of Internal medicine, limiting it down to topics relating to Emtricitabine and, in certain cases, Efavirenz, as a part of the same area of interest.
His Acquired immunodeficiency syndrome study combines topics from a wide range of disciplines, such as Test, Drug resistance and Confidence interval.
His Drug resistance research also works with subjects such as
- Regimen that connect with fields like Dolutegravir,
- Reverse transcriptase, which have a strong connection to Virology.
Between 2016 and 2021, his most popular works were:
- Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study. (196 citations)
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis (166 citations)
- Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial (120 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Acquired immunodeficiency syndrome
- Virus
Deenan Pillay mainly focuses on Demography, Public health, Drug resistance, Viral load and Acquired immunodeficiency syndrome.
His Demography research integrates issues from Young adult, Incidence, Cross-sectional study and Reproductive health.
Deenan Pillay combines subjects such as Regimen, Transmission, HIV drug resistance, Integrase and Efavirenz with his study of Drug resistance.
His Transmission research is included under the broader classification of Virology.
Deenan Pillay interconnects Internal medicine, Lamivudine, Antiretroviral therapy, Pediatrics and Population health in the investigation of issues within Viral load.
His study focuses on the intersection of Acquired immunodeficiency syndrome and fields such as Confidence interval with connections in the field of Random effects model and Sequence analysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
